329 related articles for article (PubMed ID: 17109384)
1. Risk factors for intrahepatic cholangiocarcinoma in a low-risk population: a nationwide case-control study.
Welzel TM; Mellemkjaer L; Gloria G; Sakoda LC; Hsing AW; El Ghormli L; Olsen JH; McGlynn KA
Int J Cancer; 2007 Feb; 120(3):638-41. PubMed ID: 17109384
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a case-control study in China.
Tao LY; He XD; Qu Q; Cai L; Liu W; Zhou L; Zhang SM
Liver Int; 2010 Feb; 30(2):215-21. PubMed ID: 19840244
[TBL] [Abstract][Full Text] [Related]
3. [Risk factors of intrahepatic cholangiocarcinoma: a case-control study].
Zhou HB; Xu QR; Wang H; Zhou DX; Wang H; Wang Q; Zhou SS; Tu QQ; Sun ZQ; Ai L; Wu MC; Hu HP
Zhonghua Gan Zang Bing Za Zhi; 2009 Dec; 17(12):935-9. PubMed ID: 20038337
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a hospital-based case-control study.
Shaib YH; El-Serag HB; Nooka AK; Thomas M; Brown TD; Patt YZ; Hassan MM
Am J Gastroenterol; 2007 May; 102(5):1016-21. PubMed ID: 17324130
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B virus infection and intrahepatic cholangiocarcinoma in Korea: a case-control study.
Lee TY; Lee SS; Jung SW; Jeon SH; Yun SC; Oh HC; Kwon S; Lee SK; Seo DW; Kim MH; Suh DJ
Am J Gastroenterol; 2008 Jul; 103(7):1716-20. PubMed ID: 18557716
[TBL] [Abstract][Full Text] [Related]
6. [Case-control study of risk factors in cholangiocarcinoma].
Tao LY; He XD; Cai L; Liu W; Ji WJ; Zhao L; Zhang SM
Zhonghua Zhong Liu Za Zhi; 2009 Oct; 31(10):759-63. PubMed ID: 20021829
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B virus infection, diabetes mellitus, and their synergism for cholangiocarcinoma development: a case-control study in Korea.
Lee BS; Park EC; Park SW; Nam CM; Roh J
World J Gastroenterol; 2015 Jan; 21(2):502-10. PubMed ID: 25593465
[TBL] [Abstract][Full Text] [Related]
8. Incidence rates of intra- and extrahepatic cholangiocarcinomas in Denmark from 1978 through 2002.
Jepsen P; Vilstrup H; Tarone RE; Friis S; Sørensen HT
J Natl Cancer Inst; 2007 Jun; 99(11):895-7. PubMed ID: 17551150
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study.
Welzel TM; Graubard BI; El-Serag HB; Shaib YH; Hsing AW; Davila JA; McGlynn KA
Clin Gastroenterol Hepatol; 2007 Oct; 5(10):1221-8. PubMed ID: 17689296
[TBL] [Abstract][Full Text] [Related]
10. Cholelithiasis and the risk of intrahepatic cholangiocarcinoma: a meta-analysis of observational studies.
Cai H; Kong WT; Chen CB; Shi GM; Huang C; Shen YH; Sun HC
BMC Cancer; 2015 Nov; 15():831. PubMed ID: 26526500
[TBL] [Abstract][Full Text] [Related]
11. Metabolic syndrome increases the risk of primary liver cancer in the United States: a study in the SEER-Medicare database.
Welzel TM; Graubard BI; Zeuzem S; El-Serag HB; Davila JA; McGlynn KA
Hepatology; 2011 Aug; 54(2):463-71. PubMed ID: 21538440
[TBL] [Abstract][Full Text] [Related]
12. Bile duct dysplasia in the setting of chronic hepatitis C and alcohol cirrhosis.
Torbenson M; Yeh MM; Abraham SC
Am J Surg Pathol; 2007 Sep; 31(9):1410-3. PubMed ID: 17721197
[TBL] [Abstract][Full Text] [Related]
13. Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study.
Shaib YH; El-Serag HB; Davila JA; Morgan R; McGlynn KA
Gastroenterology; 2005 Mar; 128(3):620-6. PubMed ID: 15765398
[TBL] [Abstract][Full Text] [Related]
14. Intrahepatic cholangiocarcinoma and hepatitis C and B virus infection, alcohol intake, and hepatolithiasis: a case-control study in Italy.
Donato F; Gelatti U; Tagger A; Favret M; Ribero ML; Callea F; Martelli C; Savio A; Trevisi P; Nardi G
Cancer Causes Control; 2001 Dec; 12(10):959-64. PubMed ID: 11808716
[TBL] [Abstract][Full Text] [Related]
15. Pathological spectrum of intrahepatic cholangiocarcinoma arising in non-biliary chronic advanced liver diseases.
Nakanuma Y; Xu J; Harada K; Sato Y; Sasaki M; Ikeda H; Kim J; Yu E
Pathol Int; 2011 May; 61(5):298-305. PubMed ID: 21501296
[TBL] [Abstract][Full Text] [Related]
16. Risk factors of intrahepatic cholangiocarcinoma in patients with hepatolithiasis: a case-control study.
Liu ZY; Zhou YM; Shi LH; Yin ZF
Hepatobiliary Pancreat Dis Int; 2011 Dec; 10(6):626-31. PubMed ID: 22146627
[TBL] [Abstract][Full Text] [Related]
17. [Descriptive epidemiology of intrahepatic cholangiocarcinoma].
Tsukuma H
Nihon Rinsho; 2001 Oct; 59 Suppl 6():25-32. PubMed ID: 11761949
[No Abstract] [Full Text] [Related]
18. The epidemiology of cholangiocarcinoma.
Shaib Y; El-Serag HB
Semin Liver Dis; 2004 May; 24(2):115-25. PubMed ID: 15192785
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for cholangiocarcinoma.
Ben-Menachem T
Eur J Gastroenterol Hepatol; 2007 Aug; 19(8):615-7. PubMed ID: 17625428
[TBL] [Abstract][Full Text] [Related]
20. Independent of Primary Sclerosing Cholangitis and Cirrhosis, Early Adulthood Obesity Is Associated with Cholangiocarcinoma.
Hatia RI; Eluri M; Hawk ET; Shalaby A; Karatas E; Shalaby A; Abdelhakeem A; Abdel-Wahab R; Chang P; Rashid A; Jalal PK; Amos CI; Han Y; Armaghany T; Shroff RT; Li D; Javle M; Hassan MM
Cancer Epidemiol Biomarkers Prev; 2023 Oct; 32(10):1338-1347. PubMed ID: 37540502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
